CompanyDeals

Jianke.com Files for Hong Kong IPO with Focus on Chronic Disease Management

CompanyDrug

China’s First Gene Therapy for Deafness, RRG-003, Begins Clinical Study

Policy / Regulatory

Shanghai Hosts Yangtze River Delta Alliance VBP Tender for 44 Drugs

CompanyDrug

BeiGene to Present Final PFS Results for Brukinsa at ASH Meeting

CompanyDeals

Kunshi Biotechnology and Puheng Technology Partner on 3D NAC-Organ Platform for CAR-Macrophage Screening

CompanyDeals

Endoso Life Raises Pre-Series A Funding for High-End Medical Endoscope Development

CompanyDrug

Vcanbio’s VUM02 Accepted for Review by China’s Center for Drug Evaluation

CompanyDrug

Fosun Pharma’s Human Interferon Gamma Approved for New Indication by NMPA

CompanyDrug

InnoCare Pharma’s Hibruka Receives HSA Approval for Mantle Cell Lymphoma in Singapore

CompanyDeals

Sun-Novo Pharma to Acquire MAH Rights for Azilsartan from Baiao Pharma

CompanyDeals

UB Biotechnology Secures Series A Funding for Flow Cytometry Platform

CompanyDeals

IASO Biotherapeutics Partners with Umoja Biopharma to Evaluate iCIL Platform